| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |